20.05
-0.06 (-0.3%)
-0.06 (-0.3%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.06 | -0.3% | 20.05 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 19.49 | 19.10 | 20.4612 | 20.06 | 20.11 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 16.15 | 20.05 | 3.90 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,167 | 892,323 | $ 19.94 | $ 17,795,225 | 675,898 | 1.50 - 23.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:57:06 | formt | 100 | $ 20.05 | USD |
Celldex Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 793.32M | 39.57M | 39.55M | $ 3.57M | $ - | -3.58 | -8.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.06 | 20.64 | 17.31 | 18.84 | 699,784 | 1.99 | 11.02% |
| 1 Month | 17.22 | 20.64 | 16.03 | 17.97 | 610,614 | 2.83 | 16.43% |
| 3 Months | 16.33 | 23.40 | 15.93 | 18.91 | 669,698 | 3.72 | 22.78% |
| 6 Months | 10.80 | 23.40 | 9.59 | 15.86 | 665,104 | 9.25 | 85.65% |
| 1 Year | 2.28 | 23.40 | 1.50 | 9.91 | 1,204,822 | 17.77 | 779.39% |
| 3 Years | 2.86 | 23.40 | 0.17 | 3.68 | 1,354,612 | 17.19 | 601.05% |
| 5 Years | 10.00 | 23.40 | 0.17 | 3.80 | 1,645,382 | 10.05 | 100.5% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379. |
